ERTUCO-M
ERTUGLIFLOZIN AND METFORMIN HCL · by ATCO
Composition
Tab 2.5mg/500mg: Ertugliflozin and Metformin, Tab 2.5mg/1000mg: Ertugliflozin and Metformin, Tab 7.5mg/500mg: Ertugliflozin and Metformin, Tab 7.5mg/1000mg: Ertugliflozin and Metformin
Indications & Dosage
Type 2 diabetes mellitus if monotherapy fails to achieve adequate glycaemic control: Adult: 2.5mg Ertugliflozin /500mg Metformin twice daily; increased dose as required. Max: 7.5 5mg Ertugliflozin /1000mg Metformin
Contraindications
Type 1 diabetes mellitus, severe renal impairment, end-stage renal disease, or dialysis, Pancreatitis, Ketoacidosis, hepatic impairment.
Precautions
Heart failure, moderate renal impairment, hypotension, hypoglycaemia, elderly
Interactions
Carbonic anhydrase inhibitors, insulin, insulin secretagogues, dolutegravir, ranolazine, vandetanib, cimetidine
Pregnancy
Contraindicated in pregnancy
Lactation
Contraindicated or not recommended
Side Effects
Headache, abdominal discomfort, diarrhoea, flatulence, nausea, vomiting, genital mycotic infections. Rare: Diabetic ketoacidosis (discontinue).